A multicentre efficacy and safety study of the single contraceptive implant Implanon®

Resultado de la investigación: Contribución a una revistaArtículorevisión exhaustiva

129 Citas (Scopus)

Resumen

An open, multicentre study was performed to assess efficacy, safety and acceptability of the single-rod contraceptive implant Implanon®. The study involved 635 young healthy women, who were sexually active and of childbearing potential. The women were followed up every 3 months over the entire study period. Originally the study was designed for 2 years, but was extended to 3 years in a group of 147 women from two centres. Altogether, 21 centres in nine different countries participated. The average age of the women was 29 years (range 18-42 years), of whom 83.5% had been pregnant in the past. No pregnancy occurred during treatment with Implanon®, resulting in a Pearl Index of 0 (95% confidence interval: 0.0-0.2). In the first 2 years, 31% had discontinued the treatment. Of the 147 women in the study extension, nine discontinued (6%) treatment. Bleeding irregularities was the main reason for discontinuation during the first 2 years of use (17.2%) and adverse experiences in the third year (3.4%). Implant insertion and removal were fast and uncomplicated in the vast majority (97%) of cases. Return of fertility was prompt. In conclusion, Implanon® has excellent contraceptive action during its lifetime of 3 years. The safety profile is acceptable and not essentially different from progestogens in general.

Idioma originalInglés
Páginas (desde-hasta)976-981
Número de páginas6
PublicaciónHuman Reproduction
Volumen14
N.º4
DOI
EstadoPublicada - 1999

Áreas temáticas de ASJC Scopus

  • Medicina reproductiva
  • Ginecología y obstetricia

Huella

Profundice en los temas de investigación de 'A multicentre efficacy and safety study of the single contraceptive implant Implanon®'. En conjunto forman una huella única.

Citar esto